Qube Research & Technologies »

Pyxis Oncology shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $652k 153k 4.26
2023-09-30 $4 2 2.00

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
Balyasny Asset Management
Ikarian Capital
Vanguard Group
Standard Life Aberdeen
Millennium Management
Superstring Capital Management
Boothbay Fund Management
Monashee Investment Management
Hillhouse Capital Advisors
Geode Capital Management
Goldman Sachs Group
Decheng Capital
BlackRock

View all funds holding Pyxis Oncology